The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Review of manual «Neurosurgical Diseases» by D.E. Matsko

Journal: Russian Journal of Archive of Pathology. 2016;78(2): 69‑70

DOI: 10.17116/patol201678269-70

Views: 2734

Downloaded: 1057

Download PDF (RU)
Contact the author
Table of contents

REVIEW OF MANUAL «NEUROSURGICAL DISEASES» BY D.E. MATSKO
REVIEW OF MANUAL «NEUROSURGICAL DISEASES» BY D.E. MATSKO

To cite this article:

Review of manual «Neurosurgical Diseases» by D.E. Matsko. Russian Journal of Archive of Pathology. 2016;78(2):69‑70. (In Russ.)
https://doi.org/10.17116/patol201678269-70

Подписка 2025-2 (Russian Journal of Archive of Pathology)
МСФ на ЯМ
Close metadata

The paper gives the data available in the literature on vascularization of hepatocellular carcinoma (HCC). Sinusoidal capillarization and unpaired arteries are shown to play an important role in the development and progression of HCC. The density of microvessels detected by immunohistochemical techniques is a morphological indicator of the degree of angiogenic processes. Higher-grade HCC is followed by changes in its vascularization and concurrent with a progressive increase in the proportion of blood entering along the hepatic artery. The morphological indicators of microvessel density are recommended to use as additional criteria for determining the prognosis of the disease, designing targeted anti-angiogenic drugs, and evaluating the efficiency of performed therapy.

List of references:

  1. El-Serag H.B. Hepatocellular carcinoma: recent trend in the United States. Gastroenterology. 2004; 127: S27—34.
  2. Bazin I.S. Gepatotsellyulyarnyi rak — sovremennoe sostoyanie problemy. Prakticheskaya onkologiya. 2008; 4: 216—28.
  3. Shchegolev A.I., Mishnev O.D., Tin'kova I.O. Onkomorfologiya pecheni. M.: Izdatel'stvo RGMU; 2006. 252 s.
  4. Arii S., Yamaoka Y., Futagawa S., Inoue K., Kobayashi K., Kojiro M. et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology. 2000; 32: 1224—9.
  5. Chissov V.I., Butenko A.V., Vashakmadze L.A., Sidorov D.V., Grishin N.A., Lozhkin M.V. i dr. Khirurgicheskoe lechenie pervichnogo i metastaticheskogo raka pecheni. Rossiiskii onkologicheskii zhurnal. 2010; 5: 8—12.
  6. Lo C.M., Ngan H., Tso W.K., Liu C.L., Lam C.M., Poon R.T. et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002; 35: 1164—71.
  7. Lee T.K., Poon R.T., Yuen A.P., Ling M.T., Wang X.H., Wong Y.C. et al. Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma. Clin. Cancer Res. 2006; 12: 6910—9.
  8. Zhu A.X., Duda D.G., Sahani D.V., Jain R.K. HCC and angiogenesis: possible targets and future directions. Nat. Rev. Clin. Oncol. 2011; 8 (5): 292—301.
  9. Liotta L.A., Steeg P.S., Stetler-Stevenson W.G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell. 1991; 64: 327—36.
  10. Gimbrone Jr. M.A., Cotran R.S., Leapman S.B., Folkman J. Tumor dormancy in vivo by prevention of neovascularization. J. Exp. Med. 1972; 136: 261—76.
  11. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996; 86: 353—64.
  12. Tanaka H., Yamamoto M., Hashimoto N., Miyakoshi M., Tamakawa S., Yoshie M. et al. Hypoxia-independent overexpression of hypoxia-inducible factor 1alpha as an early change in mouse hepatocarcinogenesis. Cancer Res. 2006; 66: 11263—70.
  13. Kin M., Torimura T., Ueno T., Inuzuka S., Tanikawa K. Sinusoidal capillarization in small hepatocellular carcinoma. Pathol. Int. 1994; 44: 771—8.
  14. Vidal-Vanaclocha F., Alonso-Varona A., Ayala R., Barberá-Guillem E. Functional variations in liver tissue during the implantation process of metastatic tumour cells. Virchows Archiv A. Pathol. Anat. Histopathol. 1990; 416: 189—95.
  15. Nagura T., Shiratori Y., Fukushi Y., Kiriyama H., Hai K., Takada H. et al. Morphological changes of hepatic sinusoidal cells during metastasis of colon carcinoma. In: Knook D.L., Wisse E., eds. Cells of the hepatic sinusoid. Vol. 4. Leiden: Kupffer Cell Foundation; 1993: 530—3.
  16. Ichida T., Hata K., Yamada S., Hatano T., Miyagiwa M., Miyabayashi C. et al. Subcellular abnormalities of liver sinusoidal lesions in human hepatocellular carcinoma. J. Submicrosc. Cytol. Pathol. 1990; 22 (2): 221—9.
  17. Kojiro M. Pathology of hepatocellular carcinoma. Blackwell Publ; 2006. 174 p.
  18. Chekmareva I.A., Vtyurin B.V., Dubova E.A., Shchegolev A.I. Ul'trastrukturnaya kharakteristika gepatotsellyulyarnogo raka. Arkhiv patologii. 2010; 3: 7—12.
  19. Isomura T., Nakashima T. Ultrastructure of human hepatocellular carcinoma. Acta Pathol. Jpn. 1980; 30: 713—26.
  20. Matsui O., Kobayashi S., Sanada J., Kouda W., Ryu Y., Kozaka K. et al. Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiography-assisted CT) with special reference to multistep hepatocarcinogenesis. Abdom. Imaging. 2011; 36: 264—72.
  21. Yang L.Y., Lu W.Q., Huang G.W., Huang G.W., Wang W. Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma. BMC Cancer. 2006; 6: 110.
  22. Chebib I., Shabani-Rad M.T., Chow M.S., Zhang J., Gao Z.H. Microvessel density and clinicopathologic characteristics in hepatocellular carcinoma with and without cirrhosis. Biomarker Insights. 2007; 2: 59—68.
  23. Frachon S., Gouysse G., Dumortier J., Couvelard A., Nejjari M., Mion F. et al. Endothelial cell marker expression in dysplastic lesions of the liver: an immunohistochemical study. J. Hepatol. 2001; 34 (6): 850—7.
  24. Nakashima Y., Nakashima O., Hsia C.C., Kojiro M., Tabor E. Vascularization of small hepatocellular carcinomas: correlation with differentiation. Liver. 1999; 19 (1): 12—8.
  25. Yamamoto T., Hirohashi K., Kaneda K., Ikebe T., Mikami S., Uenishi T. et al. Relationship of the microvascular type to the tumor size, arterialization and dedifferentiation of human hepatocellular carcinoma. Jpn. J. Cancer Res. 2001; 92: 1207—13.
  26. Heil M., Eitenmuller I., Schmitz-Rixen T., Schaper W. Arteriogenesis versus angiogenesis: similarities and differences. J. Cell Mol. Med. 2006; 10: 45—55.
  27. Matsui O. Analysis of intranodular hemodynamics of dysplastic nodules in cirrhotic livers. Radiology. 2001. 218: 603—5.
  28. Park Y.N., Yang C.P., Fernandez G.J., Cubukcu O., Thung S.N., Theise N.D. Neoangiogenesis and sinusoidal «capillarization» in dysplastic nodules of the liver. Am. J. Surg. Pathol. 1998; 22: 656—62.
  29. Choi B.I. The current status of imaging diagnosis of hepatocellular carcinoma. Liver Transpl. 2004; 10: S20—5.
  30. Matsui O., Takashima T., Kadoya M., Ida M., Suzuki M., Kitagawa K. et al. Dynamic computed tomography during arterial portography: the most sensitive examination for small hepatocellular carcinomas. J. Comput. Assist. Tomogr. 1985; 9: 19—24.
  31. Tumanova U.N., Dubova E.A., Karmazanovskii G.G., Shchegolev A.I. Komp'yuterno-tomograficheskaya otsenka krovosnabzheniya gepatotsellyulyarnogo raka pecheni. Annaly khirurgicheskoi gepatologii. 2013; 4: 53—60.
  32. Chen W.X., Min P.Q., Song B., Xiao B.L., Liu Y., Ge Y.H. Singlelevel dynamic spiral CT of hepatocellular carcinoma: correlation between imaging features and density of tumor microvessels. World J. Gastroenterol. 2004; 10: 67—72.
  33. Kitao A., Zen Y., Matsui O., Gabata T., Nakanuma Y. Hepatocarcinogenesis: multistep changes of drainage vessels at CT during arterial portography and hepatic arteriography — radiologic-pathologic correlation. Radiology. 2009; 252: 605—14.
  34. Tumanova U.N., Karmazanovskii G.G, Dubova E.A., Shchegolev A.I. Sravnitel'nyi analiz stepeni vaskulyarizatsii gepatotsellyulyarnogo raka i ochagovoi uzlovoi giperplazii pecheni po dannym komp'yuterno-tomograficheskogo i morfologicheskogo issledovanii. Vestnik Rossiiskoi akademii meditsinskikh nauk. 2013; 12: 9—15.
  35. Sharma S., Sharma M.C., Sarkar C. Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis. Histopathology. 2005; 46: 481—9.
  36. Vermeulen P.B., Gasparini G., Fox S.B., Colpaert C., Marson L.P., Gion M. et al. Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumors. Eur. J. Cancer. 2002; 38: 1564—79.
  37. Tanigawa N., Lu C., Mitsui T., Miura S. Quantitation of sinusoid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance. Hepatology. 1997; 26 (5): 1216—23.
  38. Poon R.T., Ng I.O., Lau C., Yu W.C., Yang Z.F., Fan S.T. et al. Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study. J. Clin. Oncol. 2002; 20: 1775—85.
  39. Geerts A.M., De Vriese A.S., Vanheule E., Van Vlierberghe H., Mortier S., Cheung K.J. et al. Increased angiogenesis and permeability in the mesenteric microvasculature of rats with cirrhosis and portal hypertension: an in vivo study. Liver Int. 2006; 26 (7): 889—98.
  40. Yao Y., Pan Y., Chen J., Sun X., Qiu Y., Ding Y. Endoglin [CD105] expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF. Ann. Clin. Lab. Sci. 2007; 37: 39—48.
  41. Shchegolev A.I., Dubova E.A., Tumanova U.N. Vaskulyarizatsiya tkani gepatotsellyulyarnogo raka zavisit ot stepeni ego differentsirovki. Byulleten' eksperimental'noi biologii i meditsiny. 2012; 4: 480—4.
  42. Messerini L., Novelli L., Comin C.E. Microvessel density and clinicopathological characteristics in hepatitis C virus and hepatitis B virus related hepatocellular carcinoma. J. Clin. Pathol. 2004; 57: 867—71.
  43. Sun X.Y., Wu Z.D., Liao X.F., Yuan J.Y. Tumor angiogenesis and its clinical significance in pediatric malignant liver tumor. World J. Gastroenterol. 2005; 11: 741—3.
  44. Paschoal J.P., Bernardo V., Canedo N.H.S., Ribeiro O.D., Caroli-Bottino A., Pannain V.L. Microvascular density of regenerative nodule to small hepatocellular carcinoma by automated analysis using CD105 and CD34 immunoexpression. BMC Cancer. 2014; 14: 72.
  45. Yu D., Zhuang L., Sun X., Chen J., Yao Y., Meng K. et al. Particular distribution and expression pattern of endoglin [CD105] in the liver of patients with hepatocellular carcinoma. BMC Cancer. 2007; 7: 122.
  46. Yagmur E., Rizk M., Stanzel S., Hellerbrand C., Lammert F., Trautwein C. Elevation of endoglin [CD105] concentrations in serum of patients with liver cirrhosis and carcinoma. Eur. J. Gastroenterol. Hepatol. 2007; 19: 755—61.
  47. Li C., Issa R., Kumar P., Hampson I.N., Lopez-Novoa J.M., Bernabeu C et al. CD105 prevents apoptosis in hypoxic endothelial cells. J. Cell Sci. 2003; 116: 2677—85.
  48. Quintanilla M., Ramirez J.R., Pérez-Gómez E., Romero D., Velasco B., Letarte M. et al. Expression of the TGF-beta coreceptor endoglin in epidermal keratinocytes and its dual role in multistage mouse skin carcinogenesis. Oncogene. 2003; 22: 5976—85.
  49. Yamamoto A., Dhar D.K., El-Assal O.N., Igarashi M., Tabara H., Nagasue N. Thymidine phosphorylase (plateletderived endothelial cell growth factor), microvessel density and clinical outcome in hepatocellular carcinoma. J. Hepatol. 1998; 29: 290—9.
  50. Kimura H., Nakajima T., Kagawa K., Deguchi T., Kakusui M., Katagishi T. et al. Angiogenesis in hepatocellular carcinoma as evaluated by CD34 immunohistochemistry. Liver. 1998; 18: 14—9.
  51. Ker C.G., Chen H.Y., Juan C.C., Lo H.W., Shen Y.Y., Chen J.S. et al. Role of angiogenesis in hepatitis and hepatocellular carcinoma. Hepatogastroenterology. 1999; 46: 646—50.
  52. Sun H.C., Tang Z.Y., Li X.M., Zhou Y.N., Sun B.R., Ma Z.C. Microvessel density of hepatocellular carcinoma: its relationship with prognosis. Cancer Res. Clin. Oncol. 1999; 125: 419—26.
  53. Chantrain C.F., DeClerck Y.A., Groshen S., McNamara G. Computerized quantification of tissue vascularization using high-resolution slide scanning of whole tumor sections. J. Histochem. Cytochem. 2003; 51: 151—8.
  54. Poon R.T, Fan S.T., Wong J. Clinical implications of circulating angiogenic factors in cancer patients. J. Clin. Oncol. 2001; 19: 1207—25.
  55. Sanz-Cameno P., Trapero-Marugán M., Chaparro M., Jones E.A., Moreno-Otero R. Angiogenesis: from chronic liver inflammation to hepatocellular carcinoma. J. Oncol. 2010; 2010: Article ID 272170. 7 p.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.